Literature DB >> 16556139

The influence of uremic serum on interleukin-1beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells.

Terumi Higuchi1, Noboru Fukuda, Chii Yamamoto, Toshio Yamazaki, Osamu Oikawa, Yoshihiko Ohnishi, Kazuyoshi Okada, Masayoshi Soma, Koichi Matsumoto.   

Abstract

We investigated whether or not uremic serum has an influence on IL-1beta and IL-1Ra production by normal peripheral blood mononuclear cells (PBMC). Four groups of subjects were divided into healthy controls and non-dialyzed patients with chronic renal failure (CRF), patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) patients. We examined cytokine concentrations and cytokine production by PBMC from a normal subject at the density of 2.5 x 10(6) cells/mL incubated with 25% serum in the medium and serum containing polymyxin-B or lipopolysaccharides (LPS). IL-1Ra concentrations in the serum of the uremic groups were significantly higher than those of the controls. In IL-1beta production by PBMC in medium with both serum and serum containing polymyxin-B, these values in the uremic groups were significantly higher than in the controls. In IL-1Ra production with serum containing polymyxin-B, these values in the uremic groups were significantly higher than in the controls. In contrast, in IL-1Ra production by PBMC in medium with serum containing LPS, these values in the uremic groups were significantly lower than in the controls. It was concluded that uremic serum not only contains nonendotoxemic cytokine-inducing substances, but also shows impaired cytokine production by PBMC in response to LPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556139     DOI: 10.1111/j.1744-9987.2006.00346.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  4 in total

1.  Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines.

Authors:  Hadja Fatima Tbahriti; Djamel Meknassi; Rachid Moussaoui; Amar Messaoudi; Lakhdar Zemour; Abbou Kaddous; Malika Bouchenak; Khedidja Mekki
Journal:  World J Nephrol       Date:  2013-05-06

2.  Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis.

Authors:  Fátima Higuera-de la Tijera; Alfredo I Servín-Caamaño; Aurora E Serralde-Zúñiga; Javier Cruz-Herrera; Eduardo Pérez-Torres; Juan M Abdo-Francis; Francisco Salas-Gordillo; José L Pérez-Hernández
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease.

Authors:  Piotr Bartnicki; Jacek Rysz; Beata Franczyk; Zbigniew Baj; Ewa Majewska
Journal:  Oxid Med Cell Longev       Date:  2016-02-29       Impact factor: 6.543

4.  Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy.

Authors:  Xiaofei Zhang; Guangda Xin; Dajun Sun
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.